Annemiek ME Walenkamp
University Medical Center Groningen
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Annemiek ME Walenkamp as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:37 UTC. Open this list on ClinicalTrials.gov
- N/ANCT03143946 · DIVIT Study Diet and Vitamin Supplementation in Patients With a Neuroendocrine TumorUniversity Medical Center Groningen · completed · Neuroendocrine Tumor · principal investigator
- Ph2NCT01472731 · Safety and Imaging Study of GC1008 in GliomaUniversity Medical Center Groningen · completed · Primary Brain Tumors · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:37 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 10:37 UTC. The ranking covers the 200 most relevant of 15 PubMed records, and a shared surname and initials can bring in a namesake. All 15 on PubMed
- 623 citationsRCR 19.3
- TGF-β Antibody Uptake in Recurrent High-Grade Glioma Imaged with 89Zr-Fresolimumab PET.J Nucl Med · 201581 citationsRCR 2.4
- A Phase II Study of the Efficacy and Safety of Oral Selinexor in Recurrent Glioblastoma.Clin Cancer Res · 202269 citationsRCR 4.1
- Web-Based Tailored Psychoeducation for Breast Cancer Patients at the Onset of the Survivorship Phase: A Multicenter Randomized Controlled Trial.J Pain Symptom Manage · 201760 citationsRCR 2.7
- Self-monitoring physical activity with a smartphone application in cancer patients: a randomized feasibility study (SMART-trial).Support Care Cancer · 201854 citationsRCR 2.7
- Epidermal growth factor receptor (EGFR) amplification rates observed in screening patients for randomized trials in glioblastoma.J Neurooncol · 201952 citationsRCR 1.9
- The impact of bevacizumab on health-related quality of life in patients treated for recurrent glioblastoma: results of the randomised controlled phase 2 BELOB trial.Eur J Cancer · 201545 citationsRCR 1.6
- Serial FLT PET imaging to discriminate between true progression and pseudoprogression in patients with newly diagnosed glioblastoma: a long-term follow-up study.Eur J Nucl Med Mol Imaging · 201825 citationsRCR 1.2
- 19 citationsRCR 1.0
- 17 citationsRCR 0.6